Corporate partnerships
A corporate partnership with DEBRA is more than philanthropy. It’s a powerful collaboration that delivers real benefits for your business while transforming lives. Together, we can provide vital support for people living with Epidermolysis Bullosa (EB) today and fund groundbreaking research that brings hope for a better tomorrow.
By partnering with us, your company can:
- Drive social impact by helping us improve care and quality of life for those affected by EB.
- Support innovation through research that aims to find effective treatments and, ultimately, a cure.
- Enhance your brand reputation by aligning with a cause that inspires employees, customers, and stakeholders.
- Engage your teams through meaningful fundraising and volunteering opportunities.
Join us in creating a world where no one suffers with EB.
Download our corporate partnerships brochure
Or please contact Ann Avarne, Corporate Partnerships Manager, for more information.
“The worst thing about EB is the pain. The pain is incredible, it is everyday pain that does not go away. Then there’s the itch. Some days there is no itch and sometimes I have days where I just can’t stop itching. The scarring of my skin, the fusion of my fingers, and the depletion of my skin tissue will only increase as I get older which will make life more difficult for me. This is why I want effective drug treatments and ultimately a cure for EB.”
Fazeel Irfan, 17
Lives with recessive dystrophic epidermolysis bullosa (RDEB)
Your company can play a part and BE the difference for EB
Corporate giving primarily will make a demonstrable, tangible difference by providing key funds for four areas that are vital to people living with EB.
Pioneering research including investing in drug repurposing programmes that aim to secure effective drug treatments for every type of EB.
Care and support to improve the quality of life for individuals and families living with EB.
Through member access to heavily subsidised DEBRA UK holiday homes located across the UK.
DEBRA UK works in partnership with the NHS to offer an enhanced EB healthcare service.
Why now?
“We live in an era of enormous scientific and medical innovation, which has created real opportunity for breakthroughs in EB research into future treatments, but these treatments are needed now; patients living with EB can’t wait, they need effective control of symptoms, better quality of life, and real hope that a cure will be found soon. With your help we can accelerate the pace and breadth of our research into treatments and together we can achieve this ambitious and essential journey to change lives and end suffering.”
Tony Byrne, CEO DEBRA UK
